About Worldwide  |     FAQs    |    Careers    |        Media Center  |    Taj Pharmaceuticals  World   |    TAJ Group
      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Noscapine HCl_top

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  
   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Noscapine HCl_left













 

 


Noscapine HCl

Formula: C22H23NO7.HCl


Noscapine HCl


M.Wt: 449.88

Formula: C22H23NO7.HCl

Solubility: Soluble to 50 mM in 1eq. HCl

Purity: >99 %

Storage: Desiccate at RT

CAS No: [912-60-7]

Chemical Name: (3S)-6,7-Dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-4-methoxy -6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-1(3H)-iso benzofuranone hydrochloride

Biological Activity:

Opioid alkaloid with several actions. Binds to tubulin, arresting cells in mitosis and inducing apoptosis. Also is an antagonist at bradykinin receptors (pA2 = 6.68), inhibits carbachol-stimulated phosphoinositol turnover and enhances forskolin-stimulated increases in cAMP levels in CNS tissues. Clinically used antitussive agent. Taj pharmaceuticals API Logo

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

      Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.